Hims & Hers Health (HIMS) News Today $49.94 +0.53 (+1.07%) As of 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why is Hims & Hers Health Up Today?Toggle Visibility of Why is Hims & Hers Health Up Today?Hims & Hers Health, Inc. (NYSE: HIMS) shares have been pressured by a wave of securities‐fraud class action filings and the loss of a key partnership, even as analysts weigh the telehealth company’s growth prospects. Bullish Commentary: The Motley Fool’s “Great News for Hims & Hers Stock Investors” article hints at catalysts that could spur a recovery after the late‐June sell-off. Analyst Comparison: Zacks highlights HIMS’ stronger earnings growth and expansion momentum relative to LifeMD, pointing to potential upside. Trading Volume Spike: American Banking News reports unusually high volume in HIMS shares, signaling elevated investor attention and possible volatility. MarketBeat Analysis: Notes a ~1.1% dip in trading and asks whether it’s “Time to Sell?”, reflecting short-term uncertainty. Partnership Cancellation: Novo Nordisk terminated its Wegovy® collaboration after alleging “deceptive” marketing, undercutting HIMS’ weight-loss ambitions. Class Action Suits: Multiple firms (Bronstein Gewirtz & Grossman; Kessler Topaz Meltzer & Check; Hagens Berman; Bernstein Liebhard; Bleichmar Fonti & Auld; Robbins Geller Rudman & Dowd; Rosen Law) have filed or alerted investors to lawsuits alleging federal securities-law violations for purchases made between April 29 and June 23, 2025. Posted 1h agoAI Generated. May Contain Errors. HIMS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Hims & Hers Health: Buy The Novo Nordisk Drama Dip1 hour ago | seekingalpha.comHIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm2 hours ago | prnewswire.comHIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit2 hours ago | prnewswire.comHIMS Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed4 hours ago | prnewswire.comHims & Hers Health (NYSE:HIMS) Trading Down 1.1% - Here's What Happened4 hours ago | marketbeat.comHims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy®– Hagens Berman5 hours ago | globenewswire.comHIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming DeadlineJune 30 at 12:30 PM | globenewswire.comHIMS LAWSUIT DEADLINE: Suffer Losses on Hims & Hers Health, Inc.? Contact BFA Law before the August 25 Securities Fraud Class Action Deadline (NYSE:HIMS)June 30 at 8:36 AM | globenewswire.comINVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJune 30 at 7:15 AM | prnewswire.comGreat News for Hims & Hers Stock InvestorsJune 30 at 5:15 AM | fool.comINVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJune 29 at 3:05 PM | globenewswire.comROSEN, A LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSJune 29 at 1:34 PM | markets.businessinsider.comHims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading Volume - Time to Buy?June 29 at 4:43 AM | americanbankingnews.comState of Alaska Department of Revenue Lowers Stock Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)June 29 at 3:21 AM | marketbeat.comWhy Is Hims & Hers Health (HIMS) Stock Soaring Today - Yahoo FinanceJune 28 at 11:07 PM | finance.yahoo.comHIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS ...June 28 at 7:42 PM | gurufocus.comHims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s futureJune 28 at 11:06 AM | msn.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMSJune 28 at 10:00 AM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMSJune 28 at 10:00 AM | globenewswire.comHims & Hers Stock Investors Need to Know This Before Buying or Selling This Growth StockJune 28 at 9:06 AM | fool.comHIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLPJune 28 at 9:05 AM | globenewswire.comHims & Hers Stock Financial Analysis Following Huge Stock Price CrashJune 28 at 8:18 AM | fool.comBREAKING HIMS NEWS: A Securities Fraud Class Action has been Filed on behalf of Hims & Hers Health, Inc. (NYSE:HIMS) Investors -- Contact BFA Law if You Lost MoneyJune 28 at 7:46 AM | globenewswire.comKessler Investment Group LLC Buys Shares of 118,728 Hims & Hers Health, Inc. (NYSE:HIMS)June 28 at 5:52 AM | marketbeat.comHims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk SpatJune 28 at 2:04 AM | msn.comHIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMSJune 27 at 10:41 PM | prnewswire.comWithout GLP-1 Hims & Hers Is A $20s Per Share Stock -- Sell CallJune 27 at 8:02 PM | seekingalpha.comHIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJune 27 at 4:00 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMSJune 27 at 3:46 PM | prnewswire.comTop Medical Stocks To Watch Now - June 27thJune 27 at 2:09 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Up 7% - Still a Buy?June 27 at 1:39 PM | marketbeat.comDeadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitJune 27 at 1:04 PM | businesswire.comHims & Hers Health (NYSE:HIMS) Sees Strong Trading Volume - Time to Buy?June 27 at 12:55 PM | marketbeat.comHIMZ: Buy For Short-Term Gains On Hims & Hers Health, But Be Wary Of The RisksJune 27 at 12:02 PM | seekingalpha.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMSJune 27 at 11:58 AM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMSJune 27 at 10:00 AM | prnewswire.comClass Action Announcement for Hims & Hers Health, Inc. (HIMS): Kessler Topaz Meltzer & Check, LLPJune 27 at 9:43 AM | globenewswire.comHims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy®- Hagens BermanJune 27 at 9:01 AM | prnewswire.comHIMS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJune 27 at 6:04 AM | businesswire.comMassive News for Hims & Hers Stock Investors!June 27 at 5:00 AM | fool.comHims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?June 27 at 4:53 AM | fool.comJim Cramer on Hims & Hers: “You Gotta Generate Some Discipline Here”June 27 at 3:52 AM | msn.comDown Over 30%, What's Going on With Hims & Hers stock?June 27 at 3:33 AM | fool.comHims & Hers Health, Inc. (NYSE: HIMS) Accused of “Illegal Mass Compounding and Deceptive Marketing†Practices; Investors Urged to Contact Award-Winning Firm, Gibbs MuraJune 26, 2025 | businesswire.com4HIMS : Behind the Scenes of Hims & Hers Health's Latest Options...June 26, 2025 | benzinga.comWhy Is Hims & Hers Health (HIMS) Stock Soaring TodayJune 26, 2025 | msn.comFaruqi & Faruqi Reminds Hims & Hers Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 - HIMSJune 26, 2025 | prnewswire.comHims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses; August 25, 2025 Deadline to file Lead Plaintiff MotionJune 26, 2025 | globenewswire.comHIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJune 26, 2025 | prnewswire.comHIMS BREAKING NEWS: A Class Action Lawsuit has been filed against Hims & Hers Health, Inc. -- Investors are Notified to Contact BFA Law to Potentially Recover Investment LossesJune 26, 2025 | businesswire.com Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos HIMS Media Mentions By Week HIMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIMS News Sentiment▼0.100.90▲Average Medical News Sentiment HIMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIMS Articles This Week▼11225▲HIMS Articles Average Week Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NTRA News Today GH News Today OPCH News Today RDNT News Today BTSG News Today SHC News Today CON News Today PRVA News Today SGRY News Today VCYT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HIMS) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.